American Association of Individual Investors1d
Which Is a Better Investment, Blueprint Medicines Corporation or Zai Lab Limited Stock?
Learn more about whether Blueprint Medicines Corporation or Zai Lab Limited is a better investment based on AAII's A+ ...
stocknews6d
3 Biotech Stocks Revolutionizing Healthcare
Driven by rapid innovations and the integration of modern technologies, the biotech sector is experiencing robust growth.
Le Lézard1d
Dynatrace Introduces Observability for Developers
Dynatrace , the leading AI-powered observability platform, today announced Observability for Developers, a comprehensive set of solutions that empower the developer community with runtime insights and ...
Le Lézard1d
Dynatrace Advances AIOps with Preventive Operations
Dynatrace , the leading AI-powered observability platform, today announced a significant expansion of its powerful AI engine, Davis® AI, that can move enterprises beyond reactive AIOps to true ...
The Impact and Trends of Review Designations in the Pharmaceutical Industry
The "Pharmaceutical Review Designations: Trends and Industry Insights" report has been added to ResearchAndMarkets.com's offering.This report investigates review designations in the pharmaceutical ...
Antibiotic Collaboration and Licensing Deals Trends and Analysis Report 2024: Access 133 Agreements Signed by the World's Leading Biopharma Companies
The "Antibiotic Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.Antibiotic Collaboration and Licensing Deals provides a comprehensive ...
pharmaphorum2d
AZ and Daiichi's TROP2 ADC shows promise in first-line lung cancer
Two years after AstraZeneca splashed out $1 billion upfront for rights to Daiichi Sankyo's TROP2-targeting antibody-drug conjugate DS-1062, the drug has generate promising results in advanced non ...